Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors.

Journal: Journal of chemical information and modeling
Published Date:

Abstract

Developing Janus kinase 2 (JAK2) inhibitors has become a significant focus for small-molecule drug discovery programs in recent years because the inhibition of JAK2 may be an effective approach for the treatment of myeloproliferative neoplasm. Here, based on three different types of fingerprints and Extreme Gradient Boosting (XGBoost) methods, we developed three groups of models in that each group contained a classification model and a regression model to accurately acquire highly potent JAK2 kinase inhibitors from the ZINC database. The three classification models resulted in Matthews correlation coefficients of 0.97, 0.94, and 0.97. Docking methods including Glide and AutoDock Vina were employed to evaluate the virtual screening effectiveness of our classification models. The of three regression models were 0.80, 0.78, and 0.80. Finally, 13 compounds were biologically evaluated, and the results showed that the IC values of six compounds were identified to be less than 100 nM. Among them, compound showed high activity and selectivity in that its IC value was less than 1 nM against JAK2 while 694 nM against JAK3. The strategy developed may be generally applicable in ligand-based virtual screening campaigns.

Authors

  • Minjian Yang
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica , Peking Union Medical College and Chinese Academy of Medical Sciences , Beijing 100050 , P.R. China.
  • Bingzhong Tao
    Joint Laboratory of Artificial Intelligence of the Institute of Materia Medica and Yuan Qi Zhi Yao , Beijing 100050 , P.R. China.
  • Chengjuan Chen
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica , Peking Union Medical College and Chinese Academy of Medical Sciences , Beijing 100050 , P.R. China.
  • Wenqiang Jia
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica , Peking Union Medical College and Chinese Academy of Medical Sciences , Beijing 100050 , P.R. China.
  • Shaolei Sun
    Joint Laboratory of Artificial Intelligence of the Institute of Materia Medica and Yuan Qi Zhi Yao , Beijing 100050 , P.R. China.
  • Tiantai Zhang
    State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica , Peking Union Medical College and Chinese Academy of Medical Sciences , Beijing 100050 , P.R. China.
  • Xiaojian Wang
    State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.